
DHSB seeks long-term capital appreciation and preservation of capital. It actively invests in US equity securities and ETFs while utilizing options and/or options spread on these investments to generate income and hedge against potential losses. The portfolio provides broad, total market exposure to the US equity space. The funds options strategy consists of two components: selling covered call options on up to 100% of the US equity portfolio to generate premiums, while simultaneously reinvesting a portion of such premium to buy near-at-the-money put options or put spreads on the same equity portfolio to hedge or mitigate the downside risk associated with owning equity securities. Due to the funds hedging nature, investors are subject to an upside return cap. The fund adviser may not employ or partially employ the options strategy based on prevailing market conditions. The issuers website provides information on the funds buffer and return cap on a daily basis.
Day Hagan Smart Buffer ETF trades as DHSB on AMEX. The company is classified in Financial Services / Asset Management and reports in USD.
The current profile places the business in Asset Management. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Detailed operating-segment data is not available for this symbol yet.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
Day Hagan Smart Buffer ETF can be compared against peers such as Innovator Premium Income 30 Barrier ETF, AllianzIM U.S. Equity Buffer10 Apr ETF, AllianzIM U.S. Equity Buffer10 Aug ETF, Bridges Capital Tactical ETF, Direxion Daily Industrials Bull 3X ETF, Trueshares Structured Outcome (July) ETF.
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of $36.98M, beta of 0.34, and return on equity of N/A.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
DHSB currently shows total debt of N/A and beta of 0.34. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://dayhagan.com/day-hagan-defined-outcome-strategy
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.